Market Updates
Europe Movers: Stratec
Inga Muller
30 May, 2025
Frankfurt
Stratec SE traded up 4.5% to €26.75 after the Germany-based provider of technologies for in-vitro diagnostics and life sciences reported strong results in the fiscal first quarter of 2025.
Sales increased to €60.36 million from €53.89 million, adjusted EBIT surged to €5.36 million from €2.92 million, and earnings per share rose to 12 cents from 2 cents a year ago.
The company said demand and new co-operations for software solutions remained strong during the quarter, such as for product cybersecurity as well as for product lifecycle management.
Stratec estimated full-year sales at constant currency to grow in a low to medium single-digit percentage range, compared to €257.6 million, and adjusted EBIT margin of around 10% to 12%, compared to 13% a year earlier, respectively.
Annual Returns
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|